Cargando…

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma

BACKGROUND: The current TNM staging system for oesophageal adenocarcinoma (OAC) has limited ability to stratify patients and inform clinical management following neo-adjuvant chemotherapy and surgery. RESULTS: Functional genomic analysis of the gene expression data using Gene Set Enrichment Analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blayney, Jaine K., Cairns, Lauren, Li, Gerald, McCabe, Niamh, Stevenson, Leanne, Peters, Christopher J., Reid, Nathan B., Spence, Veronica J., Chisambo, Chintapuza, McManus, Damian, James, Jacqueline, McQuaid, Stephen, Craig, Stephanie, Arthur, Kenneth, McArt, Darragh, Ong, Chin-Ann J., Lao-Sirieix, Pierre, Hamilton, Peter, Salto-Tellez, Manuel, Eatock, Martin, Coleman, Helen G., Fitzgerald, Rebecca C., Kennedy, Richard D., Turkington, Richard C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915089/ https://www.ncbi.nlm.nih.gov/pubmed/29719622 http://dx.doi.org/10.18632/oncotarget.24906

Ejemplares similares

Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches
por: McCabe, Niamh H., et al.
Publicado: (2022)

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study
por: McCain, R. Stephen, et al.
Publicado: (2019)

Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study
por: McCain, Stephen, et al.
Publicado: (2018)

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
por: McArt, Darragh G., et al.
Publicado: (2013)

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer
por: Humphries, Matthew P., et al.
Publicado: (2018)

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
por: Turkington, Richard C, et al.
Publicado: (2019)

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
por: Wilkinson, Richard D. A., et al.
Publicado: (2019)

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
por: Alvi, Muhammad A., et al.
Publicado: (2015)

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention
por: Buckley, Niamh, et al.
Publicado: (2015)

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study
por: McMenamin, Úna C., et al.
Publicado: (2018)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2015)

Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
por: McArt, Darragh G., et al.
Publicado: (2011)

QuPath: Open source software for digital pathology image analysis
por: Bankhead, Peter, et al.
Publicado: (2017)

Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption
por: Geaney, Alice, et al.
Publicado: (2023)

cudaMap: a GPU accelerated program for gene expression connectivity mapping
por: McArt, Darragh G, et al.
Publicado: (2013)

The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
por: Humphries, Matthew P., et al.
Publicado: (2020)

Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
por: Alderdice, Matthew, et al.
Publicado: (2021)

Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
por: Roddy, Aideen C., et al.
Publicado: (2023)

Exploring the immune microenvironment in small bowel adenocarcinoma using digital image analysis
por: Sidi, Fatima Abdullahi, et al.
Publicado: (2023)

Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
por: El Mashed, Shereen, et al.
Publicado: (2022)

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer
por: Bradley, Conor A., et al.
Publicado: (2016)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
por: Foley, Kieran G., et al.
Publicado: (2021)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis
por: McCourt, Clare M., et al.
Publicado: (2013)

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
por: Parkes, Eileen E., et al.
Publicado: (2016)

The changing face of oesophageal cancer treatment in Northern Ireland.
por: McManus, K., et al.
Publicado: (1994)

Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned
por: Li, Gerald, et al.
Publicado: (2017)

Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer
por: Lavery, Anita, et al.
Publicado: (2021)

Transdiagnostic biomarker approaches to mental health disorders: Consideration of symptom complexity, comorbidity and context
por: McQuaid, Robyn J.
Publicado: (2021)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Owens, Alice R., et al.
Publicado: (2021)

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
por: Dunne, Philip D., et al.
Publicado: (2016)

Git in Practice
por: McQuaid, Mike
Publicado: (2014)

EXPLORING HEALTHCARE WORKERS' GERIATRIC EDUCATION AND SUBSEQUENT COMMUNICATION WITH OLDER ADULTS
por: McQuaid, Tina
Publicado: (2022)

Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line
por: Blayney, Jaine K., et al.
Publicado: (2016)

Erratum to “Blood calcium as a prognostic indicator of success after surgical correction of left displaced abomasum” (JDS Commun. 2:207–211)
por: Bach, K.D., et al.
Publicado: (2022)

Blood calcium as a prognostic indicator of success after surgical correction of left displaced abomasum
por: Bach, K.D., et al.
Publicado: (2021)

The association of subclinical hypocalcemia at 4 days in milk with reproductive outcomes in multiparous Holstein cows
por: Seely, C.R., et al.
Publicado: (2022)

Cholethorax following Percutaneous Transhepatic Biliary Drainage
por: Turkington, Richard C, et al.
Publicado: (2007)

Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer
por: Millar, J, et al.
Publicado: (2005)

Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting
por: McQuaid, Fiona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ooqr6vcc9q76crnumo3o59egkt